{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["52(6)"],"submitter":["Kim DH"],"funding":["Korean Society of Hypertension"],"pubmed_abstract":["<h4>Background and objectives</h4>This study aimed to investigate the association between cardiovascular events and 2 different levels of elevated on-treatment diastolic blood pressures (DBP) in the presence of achieved systolic blood pressure targets (SBP).<h4>Methods</h4>A nation-wide population-based cohort study comprised 237,592 patients with hypertension treated. The primary endpoint was a composite of cardiovascular death, myocardial infarction, and stroke. Elevated DBP was defined according to the Seventh Report of Joint National Committee (JNC7; SBP <140 mmHg, DBP ≥90 mmHg) or to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) definitions (SBP <130 mmHg, DBP ≥80 mmHg).<h4>Results</h4>During a median follow-up of 9 years, elevated on-treatment DBP by th"],"journal":["Korean circulation journal"],"pagination":["460-474"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9160643"],"repository":["biostudies-literature"],"pubmed_title":["Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets."],"pmcid":["PMC9160643"],"pubmed_authors":["Ryu SK","Shin J","Kang SH","Chung WJ","Cho I","Shin JH","Sung KC","Kim KI","Ihm SH","Kang SM","Lee JH","Kim DH","Kim HL","Kim HM","Jung MH","Kwon CH","Lee HY","Kang DR","Park S","Cho MC","Sohn IS","Kim W","Cho IJ","Lee CJ","Kim HC","Pyun WB","Cho EJ","Kim JH"],"additional_accession":[]},"is_claimable":false,"name":"Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets.","description":"<h4>Background and objectives</h4>This study aimed to investigate the association between cardiovascular events and 2 different levels of elevated on-treatment diastolic blood pressures (DBP) in the presence of achieved systolic blood pressure targets (SBP).<h4>Methods</h4>A nation-wide population-based cohort study comprised 237,592 patients with hypertension treated. The primary endpoint was a composite of cardiovascular death, myocardial infarction, and stroke. Elevated DBP was defined according to the Seventh Report of Joint National Committee (JNC7; SBP <140 mmHg, DBP ≥90 mmHg) or to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) definitions (SBP <130 mmHg, DBP ≥80 mmHg).<h4>Results</h4>During a median follow-up of 9 years, elevated on-treatment DBP by th","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jun","modification":"2025-04-18T23:45:02.247Z","creation":"2025-02-19T03:52:12.408Z"},"accession":"S-EPMC9160643","cross_references":{"pubmed":["35388992"],"doi":["10.4070/kcj.2021.0330"]}}